Director, HTA, Evidence, and Global Access

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview As Iovance prepares to bring AMTAGVI® to patients globally outside the United States, we are seeking an individual who is experienced with HTA, Evidence, and Global Access. This role will be a critical contributor to Iovance’s HTA, evidence, and global access strategies and will report to the Senior Director, Global Market Access. The position is responsible for supporting international markets where Iovance is pursuing reimbursement, planning for new indication and products, and support of commercial activities generally. Core responsibilities include end-to-end management of health technology assessment (HTA) submissions, developing Iovance’s evidence generation activities, engagement with HTA bodies and payers, development of global value and access materials, and project management across global market access and HEOR activities. The role will also support HEOR-related activities —including research, economic modeling, and publications – and may from time to time engage in activities supporting projects from regulatory, commercial, or other teams. The Director will serve as the internal subject matter expert for HTA, access, and evidence generation in priority markets, and maintains a strong understanding of evolving health policies and reimbursement environments while building and sustaining relationships with key external stakeholders. Prior experience in oncology, rare diseases, and/or advanced therapy medicinal products (ATMPs) is highly desirable. The ideal candidate is highly organized, detail-oriented, proactive, and solutions-focused, with strong analytical and problem-solving skills. The level of this role will be aligned to the individual’s experience, competencies, and demonstrated ability relative to the requirements of the position. Essential Functions and Responsibilities Support the development and maintenance of economic models and global value dossiers for HTA submissions, managing/directing market access and HEOR consultants. Serve as project manager for global market access and HEOR activities, including tracking deliverables, coordinating document reviews, managing contracts, and ensuring alignment on timelines and cross-functional updates. Support global HEOR research projects, including review of analyses and development of publications for HTA submissions and payer responses, in collaboration with the HEOR team. Support development and execution of the evidence generation for payer needs in collaboration with medical affairs Manage external engagements, in a compliant manner, with HTA agencies, payers, key opinion leaders, and other stakeholders Communicate market access and HEOR strategy updates, insights, and recommendations to cross-functional partners and senior leadership. Develop and adapt value and access materials for priority global markets. Support planning and strategy for new indication launches, from the perspective of evidence and access Monitor and proactively communicate market access changes, challenges, and opportunities in priority markets. Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. Perform miscellaneous duties as assigned. Preferred Education, Skills, and Knowledge 12+ years of relevant experience in the biopharmaceutical industry, with demonstrated expertise in health economics, outcomes research, market access, real world evidence and/or